AbbVie Inc $53.27

down -0.16


30/7/2014 10:50 AM  |  NYSE : ABBV  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ABBV Trend Analysis - it has outperformed the S&P 500 by 2%

Partner Headlines

  1. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  2. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD
  3. UPDATE: UBS Upgrades AbbVie

    Benzinga
  4. AbbVie Beats Earnings Views, Sees Slower Humira Gain

    IBD
  5. #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth

    Benzinga
  6. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  7. Benzinga's Weekend M&A Chatter

    Benzinga
  8. AbbVie Clinches Shire Deal

    IBD
  9. Investors Focus On Earnings Rather Than Geopolitical Tensions

    Benzinga
  10. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  11. AbbVie Buys Shire For $54 Billion

    IBD
  12. Stocks Futures Up On Q2 Reports; Abbvie-Shire, Google Positive

    IBD
  13. Benzinga's Top #PreMarket Losers

    Benzinga
  14. AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares

    Benzinga
  15. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  16. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  17. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  18. Bank Of America Boosts AbbVie PT On Increased Likelihood Of Deal

    Benzinga
  19. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  20. AbbVie Near $54 Bil Shire Buy

    IBD
  21. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  22. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga
  23. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  24. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  25. Can Investors Profit From Friday's Rumors? Depends Who You Ask

    Benzinga
  26. Benzinga's Top #PreMarket Losers

    Benzinga
  27. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  28. Benzinga's Weekend M&A Chatter

    Benzinga
  29. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  30. Markets Close Higher Ahead Of Busy Earnings Season

    Benzinga
  31. Shire Shares Volatile Surrounding Speculation And Confirmation Of AbbVie ...

    Benzinga
  32. Stocks Trade Around Flat Line; Harman Clears Buy Point

    IBD
  33. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
  34. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  35. Stocks Rebound From 2 Day Drop As The Fed Confirms The End Of QE Is Near

    Benzinga
  36. Deutsche Bank Analyst Talks Up Biogen On CNBC; Stock Responds Slightly

    Benzinga
  37. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  38. #PreMarket Primer: Wednesday, July 9: Chinese CPI Cools In June

    Benzinga
  39. Benzinga's M&A Chatter for Tuesday July 8, 2014

    Benzinga
  40. AbbVie raises its bid for Shire

    IBD
  41. Memories Of March Return As Momentum Stocks Hit Hard

    Benzinga
  42. Major Indexes Cut More Losses; Alcoa Turns Up Ahead Of Earnings

    IBD
  43. Mid-Afternoon Market Update: The Fresh Market Drops Following Goldman Sachs ...

    Benzinga
  44. In Pursuit of Shire, AbbVie Eyes Lower Taxes in UK

    FoxBusiness
  45. The Fresh Market Drops Following Goldman Sachs Downgrade; Macquarie Infrastructure ...

    Benzinga
  46. AbbVie Raises Bid For Shire, But Both Stocks Fall

    IBD
  47. Markets Tumble; AbbVie Raises Offer For Shire

    Benzinga
  48. Morning Market Losers

    Benzinga
  49. Shire Offers Statement Following AbbVie Announcement, Says Board Will Meet ...

    Benzinga
  50. AbbVie Boosts Shire Offer For The 4th Time

    Benzinga
Trading Center